Target intelligence / Profile preview

Cerebral metabolic rate (CMR)

Target
CMR
Molecular classification
Other
01

Overview

Cerebral metabolic rate (CMR) is a physiological measure of the energy consumed by the brain per unit of time, typically quantified by the consumption of oxygen (CMRO2) or glucose (CMRglc) (StatPearls: Physiology, Cerebral Blood Flow, 2023). It serves as a fundamental indicator of neuronal activity and viability, as the brain has high energy demands and limited storage capacity, relying almost exclusively on oxidative metabolism of glucose for ATP production (NIH: Brain Energy Metabolism, 2021). CMR is tightly coupled with cerebral blood flow (CBF) under normal physiological conditions to ensure adequate delivery of substrates, a process known as neurovascular coupling. In clinical practice, CMR is not a molecular target but a critical biomarker used to evaluate the severity of conditions like traumatic brain injury, stroke, and neurodegeneration (Journal of Cerebral Blood Flow & Metabolism, 2012). Various pharmacological agents, particularly anesthetics and neurostimulants, are known to significantly modulate CMR by altering neuronal firing rates and synaptic transmission. Monitoring CMR via advanced neuroimaging techniques like PET or fMRI allows clinicians to assess the metabolic state of the brain and the efficacy of neuroprotective interventions.

Other names
Brain metabolismCerebral metabolic rate of oxygenCerebral metabolic rate of glucoseCMRO2CMRglc
02

Mechanism of action

Drugs modulate cerebral metabolic rate by altering neuronal excitability, synaptic transmission, or mitochondrial oxidative phosphorylation, thereby changing the demand for ATP (StatPearls: Physiology, Cerebral Blood Flow, 2023).

03

Biological functions

Energy metabolismNeuronal signalingHomeostasisATP productionOther
04

Disease associations

Neurodegenerative diseaseStrokeTraumatic brain injuryEpilepsyEncephalopathyOther
05

Safety considerations

Metabolic depressionExcitotoxicityIschemic thresholdCerebral metabolic-flow uncouplingHypometabolism
06

Interacting drugs

Propofol

6 more in the full profile.

07

Biomarkers

Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET)Oxygen-15 Positron Emission Tomography (PET)Blood-oxygen-level-dependent (BOLD) functional MRINear-infrared spectroscopy (NIRS)Arterial spin labeling (ASL) MRI

Beyond the preview

Go deeper on Cerebral metabolic rate (CMR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cerebral metabolic rate (CMR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call